EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Insmed Incorporated
15 Juillet 2016 - 8:10PM
Business Wire
Rosen Law Firm, a global investor rights law firm, announces the
filing of a class action lawsuit on behalf of purchasers of Insmed
Incorporated securities (NASDAQ: INSM) from March 18, 2013 through
June 8, 2016, both dates inclusive (the “Class Period”). The
lawsuit seeks to recover damages for Insmed investors under the
federal securities laws.
To join the Insmed class action, go to the firm’s website at
http://www.rosenlegal.com/cases-921.html or call Phillip Kim, Esq.
or Kevin Chan, Esq. toll free at 866-767-3653 or email
pkim@rosenlegal.com or kchan@rosenlegal.com for more information on
the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants
issued false and misleading statements to investors and/or failed
to disclose that: (1) the data on which Insmed’s European marketing
authorization application for Arikayce, Insmed’s lead product
candidate, relied was not likely to support approval by the
European Medicines Agency (“EMA”) for the treatment of
nontuberculous mycobacteria (“NTM”) lung disease; (2) Arikayce’s
approval by the EMA for the treatment of NTM lung disease and
subsequent commercialization in Europe were thus less likely and/or
imminent than Insmed had led investors to believe; and (3) as a
result, defendants’ statements about Insmed’s business, operations
and prospects were materially false and misleading and/or lacked a
reasonable basis at all relevant times.. When the true details
entered the market, the lawsuit claims that investors suffered
damages.
A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than
September 13, 2016. A lead plaintiff is a representative party
acting on behalf of other class members in directing the
litigation. If you wish to join the litigation, go to the firm’s
website at http://www.rosenlegal.com/cases-921.html for more
information. You may also contact Phillip Kim, Esq. or Kevin Chan,
Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at
pkim@rosenlegal.com or kchan@rosenlegal.com.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160715005735/en/
The Rosen Law Firm, P.A.Laurence Rosen, Esq.Phillip Kim,
Esq.Kevin Chan, Esq.275 Madison Avenue, 34th FloorNew York, NY
10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212)
202-3827lrosen@rosenlegal.compkim@rosenlegal.comkchan@rosenlegal.comwww.rosenlegal.com
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024